Research programme: needle-free injectables - GlideAlternative Names: Exenatide SDI®; Glide teriparatide; Teriparatide SDI®
Latest Information Update: 16 Jul 2016
At a glance
- Originator Glide Technologies
- Class Peptide hormones
- Mechanism of Action Glucagon-like peptide 1 stimulants; Osteogenesis stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Type 2 diabetes mellitus
- No development reported Osteoporosis